Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Study offers insights into post-MI fibrosis

Nov. 19, 2021

Researchers develop new model of heart failure with preserved ejection fraction

Nov. 19, 2021

Discovery of novel APJ receptor agonist with promising activity in acute hemodynamic rat model

Nov. 19, 2021

TOTUM-854 prevents the development of experimental arterial hypertension

Nov. 18, 2021

p53-PHLDA3-Akt signaling as novel therapeutic target in heart failure

Nov. 18, 2021

Stanford researchers identify means of targeting RBM20 for ameliorating diseased cardiomyocytes

Nov. 18, 2021

Novel pan-ERR agonists can provide cardioprotection against heart failure

Nov. 17, 2021

Rat model mimics the features of cerebral small vessel disease

Nov. 16, 2021

BAY-56-6544 improves vasomotor function in accelerated-aging model

Nov. 16, 2021

Seno-7284 shows efficacy in preclinical models of age-related cardiometabolic disease

Nov. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...